Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Xeplion“
Suchtreffer
Begriffe & Kennungen
Xeplion · 4.5 · Co-administration of a single dose of an oral paliperidone prolonged release tablet 12 mg with divalproex sodi
Eintrag öffnenXeplion · 4.5 · Co-administration of a single dose of an oral paliperidone prolonged release tablet 12 mg with divalproex sodi
Eintrag öffnenXeplion · 4.5 · Co-administration of oral paliperidone prolonged release once daily with carbamazepine 200 mg twice daily caus
Eintrag öffnenXeplion · 4.5 · Co-administration of oral paliperidone prolonged release once daily with carbamazepine 200 mg twice daily caus
Eintrag öffnenXeplion · 4.5 · Co-administration of oral paliperidone prolonged release tablets at steady-state (12 mg once daily) with dival
Eintrag öffnenXeplion · 4.5 · Co-administration of oral paliperidone prolonged release tablets at steady-state (12 mg once daily) with dival
Eintrag öffnenXeplion · 4.5 · Concomitant use of Xeplion with psychostimulants
Eintrag öffnenXeplion · 4.5 · Concomitant use of Xeplion with psychostimulants
Eintrag öffnenXeplion · 4.5 · Concomitant use of Xeplion with risperidone or with oral paliperidone
Eintrag öffnenXeplion · 4.5 · Given the primary central nervous system (CNS) effects of paliperidone (see section 4.8), Xeplion should be us
Eintrag öffnenXeplion · 4.5 · Given the primary central nervous system (CNS) effects of paliperidone (see section 4.8), Xeplion should be us
Eintrag öffnenXeplion · 4.5 · In vitro studies indicate that CYP2D6 and CYP3A4 may be minimally involved in paliperidone metabolism, but the
Eintrag öffnenXeplion · 4.5 · In vitro studies indicate that CYP2D6 and CYP3A4 may be minimally involved in paliperidone metabolism, but the
Eintrag öffnenXeplion · 4.5 · No interaction study between Xeplion and lithium has been performed, however, a pharmacokinetic interaction is
Eintrag öffnenXeplion · 4.5 · No interaction study between Xeplion and lithium has been performed, however, a pharmacokinetic interaction is
Eintrag öffnenXeplion · 4.5 · Paliperidone is not expected to cause clinically important pharmacokinetic interactions with medicinal product
Eintrag öffnenXeplion · 4.5 · Paliperidone is not expected to cause clinically important pharmacokinetic interactions with medicinal product
Eintrag öffnenXeplion · 4.5 · Paliperidone may antagonise the effect of levodopa and other dopamine agonists. If this combination is deemed
Eintrag öffnenXeplion · 4.5 · Paliperidone may antagonise the effect of levodopa and other dopamine agonists. If this combination is deemed
Eintrag öffnenXeplion · 4.5 · Potential for Xeplion to affect other medicines
Eintrag öffnen